Earnings Call Insights: ADMA Biologics (ADMA) Q1 2026 Management view “We had a strong start to the year with earnings growth and margin expansion despite total revenue being essentially flat, underscoring the resilience of the business,” Adam Grossman (Co-Founder, President, CEO & Director) said, adding that the quarter included “top line pressures primarily impacting BIVIGAM” while “ASCENIV end ...
Earnings Call Insights: ADMA Biologics (ADMA) Q1 2026 Management view “We had a strong start to the year with earnings growth and margin expansion despite total revenue being essentially flat, underscoring the resilience of the business,” Adam Grossman (Co-Founder, President, CEO & Director) said, adding that the quarter included “top line pressures primarily impacting BIVIGAM” while “ASCENIV end market demand reached record levels in the first quarter with revenue growth of approximately 28% year-over-year.” Grossman described an industry shift that management said disrupted ordering patterns: “Over the back half of 2025, in the first quarter of 2026, new IG products have entered the U.S. market,” and “aggressive pricing tactics, including discounting and rebating from newer entrants… drove greater-than-expected competitive intensity and distribution recalibration.” He added, “We believe these dynamics were timing related and are transitory in nature. And although it's still early, we are observing signs of reversion in the second quarter.” Grossman highlighted portfolio and pipeline catalysts, including “our recent approval for ASCENIV's pediatric label expansion” and said SG-001 preclinical data will be presented at the International Society of Pneumonia and Pneumococcal Diseases Conference; he added, “ADMA remains on track to submit its pre-IND package for SG-001 to the FDA later this year,” and said SG-001 “represents an approximately $300 million to $500 million in annual market opportunity at peak… if approved.” P. Terence Kohler (CFO & Treasurer) tied results to the competitive environment and capital allocation, stating: “Total revenue for the first quarter was $114.5 million,” and “For full year 2026, we now expect total revenue in the range of $530 million to $560 million.” Outlook Kohler guided to full-year 2026 total revenue of $530 million to $560 million, adjusted EBITDA of $265 million to $300 million, and adjusted net income of $170 million to $200 ...
Kraft Heinz Foods Co is hitting Europe’s bond market for the first time in over a year to raise euro-currency debt that will help fund a buyback of dollar notes. The issuer is seeking to raise €1 billion ($1.18 billion) evenly split across five and eight-year notes, according to a person familiar with the matter. It’s offering the shorter tranche in a range of 120 to 125 basis points above midswap...
Kraft Heinz Foods Co is hitting Europe’s bond market for the first time in over a year to raise euro-currency debt that will help fund a buyback of dollar notes. The issuer is seeking to raise €1 billion ($1.18 billion) evenly split across five and eight-year notes, according to a person familiar with the matter. It’s offering the shorter tranche in a range of 120 to 125 basis points above midswaps and the eight-year portion at 145-150 basis points above swaps. Europe’s debt market is having a far busier week than expected, with nearly €55 billion of publicly-syndicated issuance across just two days, according to data compiled by Bloomberg. Kraft Heinz is one of 15 borrowers coming to market in the busiest Thursday session in a month as hopes for a peace deal in the Middle East boost sentiment. Companies are seeking to take advantage of relatively low borrowing costs , with yields on European corporate bonds easing toward historic lows. Proceeds from Kraft Heinz’s sale will fund a planned buyback of dollar notes maturing in 2046 and 2049 that pay coupons of 4.375% and 4.875% respectively, according to a company filing. The tender offer expires on June 5. Kraft Heinz was last active in the euro debt market in February 2025 when it raised €600 million of eight-year debt, data compiled by Bloomberg show. Its new sale adds to a boom this year in US companies raising euro-currency funding, with Alphabet Inc , Danaher Corp. and Baker Hughes Co. among those to have hit the market in recent weeks. Read more: M&A Push Extends Record Rush of US Companies Selling Euro Debt See also: Alphabet Raises $17 Billion From Debt Sales for Latest AI Push Kraft Heinz’s offering is expected to price later on Thursday. Bank of America Corp, Citigroup Inc, Deutsche Bank AG, and Goldman Sachs Group Inc are arranging the sale. Issuer Profile Debt distribution: HNZ US Equity DDIS Capital structure: HNZ US Equity CAST Related securities: HNZ US Equity RELS Ratings history: HNZ US Equity CRPR Th...